Science TechnologyWednesday, 25 March 2026·The Hindu
Ayush-DBT joint clinical study on Ayurveda as adjunct therapy for tuberculosis announced on World TB Day 2026
The Ministry of Ayush and DBT announced a 24-month multi-centre clinical study on Ayurveda as an adjunct to TB treatment.
Key highlights
Direct fact
On World Tuberculosis Day 2026, the Ministry of Ayush and the Department of Biotechnology announced a 24-month multi-centre clinical study on Ayurveda as an adjunct therapy for tuberculosis.
Key specifics
- The study evaluates Ayurveda alongside standard Anti-Tuberculosis Treatment (ATT) and macronutrient supplementation.
- It focuses on TB-associated cachexia, including extreme weight loss and muscle wasting.
- Major study sites include AIIMS, JIPMER and NEIGRIHMS.
- The project is led by CCRAS in partnership with the Department of Biotechnology.
- A MoU was exchanged between BRIC-THSTI and CCRAS to formalise the collaboration.
Exam lens
Question type: science and health collaboration, institutions and duration; key facts include 24 months, ATT, AIIMS, JIPMER and NEIGRIHMS. TNPSC may ask about integrative medicine and tuberculosis research.